Trial Profile
Prospective, non-interventional, single centre clinical trial of leuprorelin combination with exemestane in the treatment of premature menopause metastatic breast caner
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary) ; Exemestane
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 16 Apr 2016 Status changed from not yet recruiting to completed.
- 12 Oct 2013 New trial record